Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
8,889,119
-
Shares change
-
+196,610
-
Total reported value, excl. options
-
$43,557,000
-
Value change
-
+$395,680
-
Number of buys
-
9
-
Number of sells
-
-13
-
Price
-
$4.90
Significant Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q4 2016
28 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q4 2016.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,889,119 shares
of 105,365,368 outstanding shares and own 8.4% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (2,585,047 shares), ORBIMED ADVISORS LLC (2,305,446 shares), Redmile Group, LLC (1,578,174 shares), Clearbridge Investments, LLC (499,213 shares), JANUS CAPITAL MANAGEMENT LLC (393,860 shares), FRANKLIN RESOURCES INC (309,700 shares), FMR LLC (237,916 shares), BAKER BROS. ADVISORS LP (212,698 shares), ALTRINSIC GLOBAL ADVISORS LLC (210,556 shares), and SPHERA FUNDS MANAGEMENT LTD. (200,000 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.